Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 17th July 2024
Solactive Global Health Services & Technology Americas:
In the ordinary adjustment, the following composition will be implemented effective open 17th July 2024:
| ABBOTT LABORATORIES |
| ABBVIE INC |
| AMEDISYS INC |
| BAXTER INTL. |
| BECTON DICKINSON AND CO |
| BIOGEN INC |
| BOSTON SCIENTIFIC CORP |
| BRISTOL-MYERS SQUIBB CO |
| CATALENT INC |
| CENTENE CORP |
| CEREVEL THERAPEUTICS HOLDINGS INC |
| CHEMED CORP |
| THE CIGNA GROUP |
| COOPER COMPANIES INC |
| DANAHER CORP |
| DENTSPLY SIRONA INC |
| ELEVANCE HEALTH INC |
| ELI LILLY & CO |
| ENCOMPASS HEALTH CORP |
| ENSIGN GROUP INC |
| EXELIXIS INC |
| GILEAD SCIENCES INC |
| HAEMONETICS CORP |
| HCA HEALTHCARE INC |
| HOLOGIC INC |
| IDEXX LABORATORIES INC |
| INCYTE CORP |
| INNOVIVA INC |
| INTUITIVE SURGICAL INC |
| JOHNSON & JOHNSON |
| LABCORP HOLDINGS INC |
| MEDTRONIC PLC |
| MERCK & CO. INC. |
| MERIT MEDICAL SYSTEMS INC |
| MOLINA HEALTHCARE INC |
| NATIONAL HEALTHCARE CORP |
| NEUROCRINE BIOSCIENCES INC |
| OLINK HOLDING AB – ADR |
| OPTION CARE HEALTH INC |
| PFIZER INC |
| PREMIER INC |
| PRESTIGE CONSUMER HEALTHCARE INC |
| QIAGEN NV |
| QUEST DIAGNOSTICS INC |
| REGENERON PHARMACEUTICALS |
| REVVITY INC |
| ROYALTY PHARMA PLC- CL A |
| STERIS PLC |
| STRYKER CORP |
| TELEFLEX INC |
| THERMO FISHER SCIENTIFIC INC |
| U.S. PHYSICAL THERAPY INC |
| UNITED THERAPEUTICS CORP |
| UNITEDHEALTH GROUP INC |
| UNIVERSAL HEALTH SVS.B |
| VERTEX PHARMACEUTICALS INC |
| VIATRIS INC |
| ZIMMER BIOMET HOLDINGS INC |